• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    FDA warns that Tydemy, a oral contraceptive, may have reduced effectiveness

    FDA

    Lupin Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of 2 Lots of Tydemy™ (Drospirenone, Ethinyl Estradiol and Levomefolate Calcium Tablets 3mg/0.03mg/0.451mg and Levomefolate Calcium Tablets 0.451mg) Due to Out of Specification (OOS) Results at the 12-month Stability Time Point

    FDA

    Lupin Pharma Issues Voluntary Nationwide Recall of 2 Lots of TydemyTM

    PR NEWSWIRE

    Lupin recalls 4,113 cartons of oral contraceptive medicine in US market

    ECONOMICTIMES

    Enforcement Report - Week of December 08, 2021

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.